Scott Thomas Jackson - May 18, 2021 Form 4 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
Director
Signature
/s/ Brian F. Leaf, attorney-in-fact
Stock symbol
GLYC
Transactions as of
May 18, 2021
Transactions value $
$0
Form type
4
Date filed
5/27/2021, 08:55 PM
Previous filing
May 17, 2021
Next filing
Aug 18, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLYC Common Stock Award $0 +5.25K $0.00 5.25K May 18, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLYC Stock Option (right to buy) Award $0 +10.5K $0.00 10.5K May 18, 2021 Common Stock 10.5K $2.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The security represents restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
F2 The shares underlying these restricted stock units vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date.
F3 The shares underlying this option vest on May 18, 2022, subject to the reporting person's continuous service as of such vesting date.